Greycoat Research Expert Guidance for CKD Cats
With over 1,000 consultation cases worldwide, Greycoat Research provides expert-backed guidance for cats with chronic kidney disease (CKD), helping them maintain kidney health and manage the progression of CKD through data-driven care.
Dr. Toru Miyazaki was the first to uncover the mechanism behind cat CKD.
Greycoat Research is guided by a team of experts dedicated to advancing feline kidney care.
- Dr. Toru Miyazaki, a leading authority on AIM research, has been instrumental in developing innovative approaches to CKD management.
- Dr. Kim Jae-young, a Korean veterinarian, gained recognition for his exceptional care of Minky, the longest-living cat in Korea at 28 years old.
- Dr. Kobayashi Motoo, a Japanese veterinarian with over 30 years of clinical experience, was the first to apply AIM in feline kidney treatment.
Their combined expertise helps shape effective CKD care solutions for cats worldwide.
Naro, a 17-year-old Persian, had been diagnosed with CKD stage 2 and had been receiving treatment for 2 years before beginning AIM supplementation in March 2024. Her blood test results fluctuated at times, but overall, her kidney values remained relatively stable. After starting AIM supplementation, her creatinine and BUN levels decreased, while his phosphorus levels slightly increased.
Meet Naro
- Breed: Persian
- Age: 17 years
- Sex: Spayed Female
- Weight: 4.9 kg (March 2024) → 4.8 kg (September 2024) → 4.6 kg (October 2024)
- Conditions: Chronic kidney disease (CKD, stage 2), hypertrophic cardiomyopathy (HCM), high blood pressure, arthritis (September)
- Symptoms & Concerns: CKD progression, weight changes, arthritis-related mobility concerns
- Previous Treatments: Renal probiotics, omega-3, phosphorus binder, blood pressure medication, subcutaneous fluids
- Supplements Introduced: Dr. Toru Protocol (March 2024), Intensive Protocol (September 2024), joint support supplement (September 2024)
Naro’s Health Improvements
Naro began AIM supplementation in March 2024. By April, her bloodwork showed early signs of stability, and by October, improvements were evident.
| Health Metric | April 2024 (1 Month AIM) | October 2024 (7 Months AIM) | Change |
|---|---|---|---|
| Creatinine (CRE) | 2.3 | 1.9 | Decreased (Kidney filtration stabilized) |
| BUN Levels | 36 | 31 | Decreased (Improved waste management) |
| SDMA Levels | 12 | 13 | Minor fluctuation (Overall stable) |
| Phosphorus Levels | 5.0 | 5.7 | Increased (Requires monitoring) |
| Weight | 4.9 kg | 4.6 kg | Decreased (Aging-related muscle loss) |
How Did Naro Improve?
Energy & Activity
- Maintained stable activity levels despite his advanced age.
- Continued normal daily behaviors, such as regular eating and movement.
- Although no major behavioral changes were noted, her owner observed that her energy levels remained steady.
Weight & Appetite
- Naro’s weight increased from 4.1 kg to 4.9 kg after early AIM supplementation, but later decreased slightly.
- Her appetite remained stable, with no major concerns.
- Weight loss in later months was attributed to natural aging-related muscle loss, according to her veterinarian.
Supplement Adjustments
- Dr. Toru Protocol was introduced in March 2024.
- Intensive Protocol was added in September 2024 to further support her condition.
- Joint support supplements were introduced in September 2024 to manage arthritis symptoms.
- Initially given AIM supplementation every other day alongside a different renal supplement, but later transitioned to daily AIM supplementation instead.
Over 7 months of AIM-based care, Naro’s creatinine and BUN levels improved, indicating better kidney waste filtration. While her phosphorus levels required monitoring, her overall condition remained stable, and her arthritis symptoms improved with additional supplements. Her consistent energy levels and stable appetite reassured her owner that AIM supplementation was contributing to her long-term health management, and her owner made the decision to add Intensive Protocol to Naro's care routine.
Testimonial from Naro’s Owner
"Naro was diagnosed with CKD stage 2 and has been under careful management for the past 2 years. I started giving her AIM supplements in March, alternating them with a different renal supplement, and I wasn’t expecting dramatic changes right away. However, when I got her bloodwork results, I was happy to see that her creatinine and BUN levels had dropped! Her weight fluctuated a little, but the vet says it's natural given her age, and her appetite and energy levels have remained stable, which is a huge relief. I've decided to replace the other renal supplement with Dr. Toru Protocol so Naro can take them every day!"
Help Your Cat Live Healthier with CKD Support
CKD is a progressive and irreversible disease that gradually impairs kidney function. Because many cats show no symptoms until significant damage has occurred, early detection and management is key to delaying its progression and preserving quality of life.
Greycoat Research has provided consultations for over 1,000 cats, with 97% of stage 2 and 3 cats showing improved kidney health after following our tailored management plans. If your cat has been diagnosed with CKD or has high creatinine levels, taking action now can lead to lasting improvements.
- Try AIM-based supplements, including Dr. Toru Protocol, along with additional kidney support.
- Monitor kidney health regularly and adjust treatment plans as needed.
- Schedule a free consultation with Greycoat Research for expert guidance.
